Abbvie Inc Stock Price To Book
| 4AB Stock | EUR 173.96 1.94 1.10% |
AbbVie Inc fundamentals help investors to digest information that contributes to AbbVie's financial success or failures. It also enables traders to predict the movement of AbbVie Stock. The fundamental analysis module provides a way to measure AbbVie's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AbbVie stock.
AbbVie |
AbbVie Inc Company Price To Book Analysis
AbbVie's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current AbbVie Price To Book | 18.07 X |
Most of AbbVie's fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AbbVie Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, AbbVie Inc has a Price To Book of 18.0664 times. This is 29.65% lower than that of the Healthcare sector and about the same as Drug Manufacturers - Major (which currently averages 18.24) industry. The price to book for all Germany stocks is 89.97% lower than that of the firm.
AbbVie Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AbbVie's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AbbVie could also be used in its relative valuation, which is a method of valuing AbbVie by comparing valuation metrics of similar companies.AbbVie is currently under evaluation in price to book category among its peers.
AbbVie Fundamentals
| Return On Equity | 0.72 | |||
| Return On Asset | 0.0991 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.39 % | |||
| Current Valuation | 331.38 B | |||
| Shares Outstanding | 1.77 B | |||
| Shares Owned By Insiders | 0.12 % | |||
| Shares Owned By Institutions | 71.51 % | |||
| Price To Earning | 22.27 X | |||
| Price To Book | 18.07 X | |||
| Price To Sales | 4.72 X | |||
| Revenue | 58.05 B | |||
| Gross Profit | 41.53 B | |||
| EBITDA | 24.17 B | |||
| Net Income | 11.84 B | |||
| Cash And Equivalents | 5.23 B | |||
| Cash Per Share | 3.54 X | |||
| Total Debt | 59.13 B | |||
| Current Ratio | 1.04 X | |||
| Book Value Per Share | 9.75 X | |||
| Cash Flow From Operations | 24.94 B | |||
| Earnings Per Share | 6.25 X | |||
| Price To Earnings To Growth | 1.29 X | |||
| Target Price | 127.01 | |||
| Number Of Employees | 50 K | |||
| Beta | 0.58 | |||
| Market Capitalization | 256.3 B | |||
| Total Asset | 138.81 B | |||
| Z Score | 2.4 | |||
| Annual Yield | 0.04 % | |||
| Five Year Return | 3.39 % | |||
| Net Asset | 138.81 B | |||
| Last Dividend Paid | 5.71 |
About AbbVie Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AbbVie Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AbbVie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AbbVie Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in AbbVie Stock
When determining whether AbbVie Inc is a strong investment it is important to analyze AbbVie's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AbbVie's future performance. For an informed investment choice regarding AbbVie Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..